» Articles » PMID: 7748178

The Cryptic Life Style of Adeno-associated Virus

Overview
Journal Bioessays
Publisher Wiley
Date 1995 Mar 1
PMID 7748178
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

Although 80-90% of adults are seropositive for antibodies against the human parvovirus adeno-associated virus (AAV), infection has not been associated with either symptoms or disease. In cell culture, AAV infection is not productive unless there is a coinfection with a helper virus, either adenovirus or any type of herpes virus; in the absence of a helper virus coinfection the viral genome is integrated into the genome, usually at a specific site on chromosome 19q13.3-qter. The integrated genome can be activated and rescued by subsequent super infection by a helper virus. The high frequency of site-specific integration by AAV and the lack of associated disease have encouraged the use of AAV as a vector for gene therapy. This review will focus on the molecular mechanisms involved in the establishment of, and rescue from, the latent state and their relevance to use of AAV as a vector.

Citing Articles

Designing and optimizing AAV-mediated gene therapy for neurodegenerative diseases: from bench to bedside.

Xu L, Yao S, Ding Y, Xie M, Feng D, Sha P J Transl Med. 2024; 22(1):866.

PMID: 39334366 PMC: 11429861. DOI: 10.1186/s12967-024-05661-2.


A tale of caution: How endogenous viral elements affect virus discovery in transcriptomic data.

Brait N, Hackl T, Morel C, Exbrayat A, Gutierrez S, Lequime S Virus Evol. 2024; 10(1):vead088.

PMID: 38516656 PMC: 10956553. DOI: 10.1093/ve/vead088.


PNMA2 forms immunogenic non-enveloped virus-like capsids associated with paraneoplastic neurological syndrome.

Xu J, Erlendsson S, Singh M, Holling G, Regier M, Ibiricu I Cell. 2024; 187(4):831-845.e19.

PMID: 38301645 PMC: 10922747. DOI: 10.1016/j.cell.2024.01.009.


Molecular Mechanisms in Pathophysiology of Mucopolysaccharidosis and Prospects for Innovative Therapy.

Ago Y, Rintz E, Musini K, Ma Z, Tomatsu S Int J Mol Sci. 2024; 25(2).

PMID: 38256186 PMC: 10816168. DOI: 10.3390/ijms25021113.


Combined Nano-Vector Mediated-Transfer to Suppress HIV-1 Infection with Targeted Antibodies in-vitro.

Yao X, Wang Q, Han C, Nie J, Chang Y, Xu L Int J Nanomedicine. 2023; 18:4635-4645.

PMID: 37605734 PMC: 10440090. DOI: 10.2147/IJN.S412915.